Early promise for laser cancer treatment:
This article was originally published in Clinica
Preclinical tests of a new laser-based cancer treatment system have shown it to be 100% effective at destroying certain cancers of the bladder and vocal cord. The device, called a phototherapeutic resonancy system, is designed to target cancerous cells specifically without damaging healthy tissue. Lasertec, which makes the system, plans to begin animal studies immediately.
You may also be interested in...
The AAM has cited multiple reasons for the failure of Medicare Part D to get new generics to its patients, forcing up their costs. The association has offered a list of suggestions to “ensure that first generics are covered at launch, with lower cost-sharing.”
The US FDA is updating its labeling guidance on laparoscopic power morcellation to reflect new evidence showing the treatment may pose a higher cancer risk in older women, as well as to add discussion of containment systems.
Rutgers University professor testifies in support of bill directing the FDA to designate National Centers of Excellence in Continuous Manufacturing; other bills target generic labeling, orphan exclusivity and counterfeit devices.